nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—ABCB1—ovarian cancer	0.222	1	CbGaD
Rilpivirine—NR1I2—Paclitaxel—ovarian cancer	0.168	0.249	CbGbCtD
Rilpivirine—NR1I2—Docetaxel—ovarian cancer	0.122	0.18	CbGbCtD
Rilpivirine—SLCO1B3—Paclitaxel—ovarian cancer	0.0661	0.0977	CbGbCtD
Rilpivirine—ABCG2—Topotecan—ovarian cancer	0.0617	0.0914	CbGbCtD
Rilpivirine—SLCO1B3—Docetaxel—ovarian cancer	0.0478	0.0707	CbGbCtD
Rilpivirine—ABCG2—Paclitaxel—ovarian cancer	0.0306	0.0452	CbGbCtD
Rilpivirine—ABCG2—Carboplatin—ovarian cancer	0.0288	0.0426	CbGbCtD
Rilpivirine—ABCB1—Topotecan—ovarian cancer	0.0223	0.0329	CbGbCtD
Rilpivirine—ABCG2—Docetaxel—ovarian cancer	0.0221	0.0327	CbGbCtD
Rilpivirine—ABCG2—Doxorubicin—ovarian cancer	0.0165	0.0244	CbGbCtD
Rilpivirine—ABCB1—Vinorelbine—ovarian cancer	0.0157	0.0232	CbGbCtD
Rilpivirine—CYP3A4—Topotecan—ovarian cancer	0.0133	0.0197	CbGbCtD
Rilpivirine—CYP2B6—Doxorubicin—ovarian cancer	0.0116	0.0171	CbGbCtD
Rilpivirine—ABCB1—Paclitaxel—ovarian cancer	0.011	0.0163	CbGbCtD
Rilpivirine—CYP3A4—Vinorelbine—ovarian cancer	0.0094	0.0139	CbGbCtD
Rilpivirine—ABCB1—Docetaxel—ovarian cancer	0.00797	0.0118	CbGbCtD
Rilpivirine—CYP3A4—Paclitaxel—ovarian cancer	0.0066	0.00977	CbGbCtD
Rilpivirine—ABCB1—Doxorubicin—ovarian cancer	0.00594	0.00879	CbGbCtD
Rilpivirine—CYP3A4—Docetaxel—ovarian cancer	0.00477	0.00706	CbGbCtD
Rilpivirine—Bilirubin total increased—Vinorelbine—ovarian cancer	0.00427	0.0558	CcSEcCtD
Rilpivirine—CYP3A4—Doxorubicin—ovarian cancer	0.00356	0.00527	CbGbCtD
Rilpivirine—Nephrotic syndrome—Chlorambucil—ovarian cancer	0.00233	0.0305	CcSEcCtD
Rilpivirine—Bilirubin total increased—Epirubicin—ovarian cancer	0.00164	0.0215	CcSEcCtD
Rilpivirine—Transaminases increased—Melphalan—ovarian cancer	0.00161	0.0211	CcSEcCtD
Rilpivirine—Etravirine—ABCB1—ovarian cancer	0.00158	0.697	CrCbGaD
Rilpivirine—Bilirubin total increased—Doxorubicin—ovarian cancer	0.00152	0.0199	CcSEcCtD
Rilpivirine—Hepatotoxicity—Chlorambucil—ovarian cancer	0.00146	0.0191	CcSEcCtD
Rilpivirine—Opportunistic infection—Paclitaxel—ovarian cancer	0.00143	0.0187	CcSEcCtD
Rilpivirine—Transaminases increased—Vinorelbine—ovarian cancer	0.00141	0.0184	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Topotecan—ovarian cancer	0.00106	0.0139	CcSEcCtD
Rilpivirine—Decreased appetite—Altretamine—ovarian cancer	0.000983	0.0128	CcSEcCtD
Rilpivirine—Fatigue—Altretamine—ovarian cancer	0.000975	0.0127	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Vinorelbine—ovarian cancer	0.000907	0.0118	CcSEcCtD
Rilpivirine—Creatinine increased—Vinorelbine—ovarian cancer	0.000901	0.0118	CcSEcCtD
Rilpivirine—Opportunistic infection—Epirubicin—ovarian cancer	0.000819	0.0107	CcSEcCtD
Rilpivirine—Asthenia—Altretamine—ovarian cancer	0.000811	0.0106	CcSEcCtD
Rilpivirine—Infection—Carboplatin—ovarian cancer	0.000776	0.0101	CcSEcCtD
Rilpivirine—Opportunistic infection—Doxorubicin—ovarian cancer	0.000758	0.0099	CcSEcCtD
Rilpivirine—Dizziness—Altretamine—ovarian cancer	0.000748	0.00977	CcSEcCtD
Rilpivirine—Vomiting—Altretamine—ovarian cancer	0.000719	0.00939	CcSEcCtD
Rilpivirine—Haemoglobin decreased—Docetaxel—ovarian cancer	0.00071	0.00928	CcSEcCtD
Rilpivirine—Pazopanib—ABCB1—ovarian cancer	0.000688	0.303	CrCbGaD
Rilpivirine—Nausea—Altretamine—ovarian cancer	0.000671	0.00878	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Topotecan—ovarian cancer	0.000655	0.00856	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Topotecan—ovarian cancer	0.000642	0.00839	CcSEcCtD
Rilpivirine—Hepatotoxicity—Docetaxel—ovarian cancer	0.000633	0.00827	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Paclitaxel—ovarian cancer	0.00061	0.00797	CcSEcCtD
Rilpivirine—Blood creatinine increased—Vinorelbine—ovarian cancer	0.000583	0.00762	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Vinorelbine—ovarian cancer	0.000561	0.00733	CcSEcCtD
Rilpivirine—Transaminases increased—Epirubicin—ovarian cancer	0.000542	0.00708	CcSEcCtD
Rilpivirine—Serum creatinine increased—Epirubicin—ovarian cancer	0.000536	0.00701	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Topotecan—ovarian cancer	0.00053	0.00693	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Melphalan—ovarian cancer	0.000519	0.00679	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Docetaxel—ovarian cancer	0.000517	0.00676	CcSEcCtD
Rilpivirine—Inflammation—Docetaxel—ovarian cancer	0.000504	0.00659	CcSEcCtD
Rilpivirine—Transaminases increased—Doxorubicin—ovarian cancer	0.000502	0.00655	CcSEcCtD
Rilpivirine—Serum creatinine increased—Doxorubicin—ovarian cancer	0.000496	0.00648	CcSEcCtD
Rilpivirine—Urinary tract disorder—Melphalan—ovarian cancer	0.000487	0.00636	CcSEcCtD
Rilpivirine—Urethral disorder—Melphalan—ovarian cancer	0.000483	0.00632	CcSEcCtD
Rilpivirine—Immune system disorder—Topotecan—ovarian cancer	0.000455	0.00594	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Vinorelbine—ovarian cancer	0.000454	0.00593	CcSEcCtD
Rilpivirine—Immune system disorder—Melphalan—ovarian cancer	0.000445	0.00582	CcSEcCtD
Rilpivirine—Renal impairment—Paclitaxel—ovarian cancer	0.00044	0.00575	CcSEcCtD
Rilpivirine—Malnutrition—Topotecan—ovarian cancer	0.000438	0.00573	CcSEcCtD
Rilpivirine—Infection—Chlorambucil—ovarian cancer	0.000399	0.00522	CcSEcCtD
Rilpivirine—Blood creatinine increased—Paclitaxel—ovarian cancer	0.000392	0.00513	CcSEcCtD
Rilpivirine—Immune system disorder—Vinorelbine—ovarian cancer	0.000389	0.00508	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Paclitaxel—ovarian cancer	0.000377	0.00493	CcSEcCtD
Rilpivirine—Malnutrition—Vinorelbine—ovarian cancer	0.000375	0.0049	CcSEcCtD
Rilpivirine—Renal impairment—Docetaxel—ovarian cancer	0.000373	0.00487	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.000371	0.00484	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Paclitaxel—ovarian cancer	0.000369	0.00483	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000363	0.00474	CcSEcCtD
Rilpivirine—Infection—Topotecan—ovarian cancer	0.000355	0.00464	CcSEcCtD
Rilpivirine—Nervous system disorder—Topotecan—ovarian cancer	0.000351	0.00458	CcSEcCtD
Rilpivirine—Decreased appetite—Chlorambucil—ovarian cancer	0.000349	0.00456	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Epirubicin—ovarian cancer	0.000349	0.00456	CcSEcCtD
Rilpivirine—Infection—Melphalan—ovarian cancer	0.000348	0.00455	CcSEcCtD
Rilpivirine—Skin disorder—Topotecan—ovarian cancer	0.000347	0.00454	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000347	0.00453	CcSEcCtD
Rilpivirine—Creatinine increased—Epirubicin—ovarian cancer	0.000346	0.00453	CcSEcCtD
Rilpivirine—Fatigue—Chlorambucil—ovarian cancer	0.000346	0.00453	CcSEcCtD
Rilpivirine—Skin disorder—Melphalan—ovarian cancer	0.00034	0.00445	CcSEcCtD
Rilpivirine—Inflammation—Epirubicin—ovarian cancer	0.00034	0.00444	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000329	0.00429	CcSEcCtD
Rilpivirine—Abnormal dreams—Epirubicin—ovarian cancer	0.000326	0.00426	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Doxorubicin—ovarian cancer	0.000323	0.00422	CcSEcCtD
Rilpivirine—Depression—Paclitaxel—ovarian cancer	0.000322	0.0042	CcSEcCtD
Rilpivirine—Creatinine increased—Doxorubicin—ovarian cancer	0.000321	0.00419	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.00032	0.00418	CcSEcCtD
Rilpivirine—Abdominal pain—Chlorambucil—ovarian cancer	0.000318	0.00415	CcSEcCtD
Rilpivirine—Renal failure—Paclitaxel—ovarian cancer	0.000317	0.00415	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000317	0.00414	CcSEcCtD
Rilpivirine—Inflammation—Doxorubicin—ovarian cancer	0.000315	0.00411	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.000313	0.00409	CcSEcCtD
Rilpivirine—Decreased appetite—Topotecan—ovarian cancer	0.000311	0.00406	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000309	0.00404	CcSEcCtD
Rilpivirine—Fatigue—Topotecan—ovarian cancer	0.000308	0.00403	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.000305	0.00399	CcSEcCtD
Rilpivirine—Decreased appetite—Melphalan—ovarian cancer	0.000304	0.00398	CcSEcCtD
Rilpivirine—Infection—Vinorelbine—ovarian cancer	0.000304	0.00397	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000302	0.00395	CcSEcCtD
Rilpivirine—Fatigue—Melphalan—ovarian cancer	0.000302	0.00395	CcSEcCtD
Rilpivirine—Abnormal dreams—Doxorubicin—ovarian cancer	0.000302	0.00394	CcSEcCtD
Rilpivirine—Nervous system disorder—Vinorelbine—ovarian cancer	0.0003	0.00392	CcSEcCtD
Rilpivirine—Skin disorder—Vinorelbine—ovarian cancer	0.000297	0.00388	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Topotecan—ovarian cancer	0.000292	0.00382	CcSEcCtD
Rilpivirine—Asthenia—Chlorambucil—ovarian cancer	0.000288	0.00377	CcSEcCtD
Rilpivirine—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000286	0.00374	CcSEcCtD
Rilpivirine—Urethral disorder—Paclitaxel—ovarian cancer	0.000284	0.00371	CcSEcCtD
Rilpivirine—Abdominal pain—Topotecan—ovarian cancer	0.000283	0.0037	CcSEcCtD
Rilpivirine—Diarrhoea—Chlorambucil—ovarian cancer	0.000275	0.00359	CcSEcCtD
Rilpivirine—Renal failure—Docetaxel—ovarian cancer	0.000269	0.00351	CcSEcCtD
Rilpivirine—Decreased appetite—Vinorelbine—ovarian cancer	0.000266	0.00348	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000264	0.00345	CcSEcCtD
Rilpivirine—Fatigue—Vinorelbine—ovarian cancer	0.000264	0.00345	CcSEcCtD
Rilpivirine—Immune system disorder—Paclitaxel—ovarian cancer	0.000262	0.00342	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000259	0.00338	CcSEcCtD
Rilpivirine—Asthenia—Topotecan—ovarian cancer	0.000257	0.00335	CcSEcCtD
Rilpivirine—Vomiting—Chlorambucil—ovarian cancer	0.000255	0.00334	CcSEcCtD
Rilpivirine—Mental disorder—Paclitaxel—ovarian cancer	0.000254	0.00332	CcSEcCtD
Rilpivirine—Malnutrition—Paclitaxel—ovarian cancer	0.000252	0.0033	CcSEcCtD
Rilpivirine—Renal impairment—Epirubicin—ovarian cancer	0.000252	0.00329	CcSEcCtD
Rilpivirine—Asthenia—Melphalan—ovarian cancer	0.000251	0.00328	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00025	0.00327	CcSEcCtD
Rilpivirine—Diarrhoea—Topotecan—ovarian cancer	0.000245	0.0032	CcSEcCtD
Rilpivirine—Urinary tract disorder—Docetaxel—ovarian cancer	0.000242	0.00317	CcSEcCtD
Rilpivirine—Abdominal pain—Vinorelbine—ovarian cancer	0.000242	0.00316	CcSEcCtD
Rilpivirine—Urethral disorder—Docetaxel—ovarian cancer	0.000241	0.00315	CcSEcCtD
Rilpivirine—Diarrhoea—Melphalan—ovarian cancer	0.00024	0.00313	CcSEcCtD
Rilpivirine—Nausea—Chlorambucil—ovarian cancer	0.000239	0.00312	CcSEcCtD
Rilpivirine—Dizziness—Topotecan—ovarian cancer	0.000237	0.00309	CcSEcCtD
Rilpivirine—Renal impairment—Doxorubicin—ovarian cancer	0.000233	0.00304	CcSEcCtD
Rilpivirine—Vomiting—Topotecan—ovarian cancer	0.000227	0.00297	CcSEcCtD
Rilpivirine—Rash—Topotecan—ovarian cancer	0.000226	0.00295	CcSEcCtD
Rilpivirine—Dermatitis—Topotecan—ovarian cancer	0.000225	0.00294	CcSEcCtD
Rilpivirine—Blood creatinine increased—Epirubicin—ovarian cancer	0.000224	0.00293	CcSEcCtD
Rilpivirine—Headache—Topotecan—ovarian cancer	0.000224	0.00293	CcSEcCtD
Rilpivirine—Vomiting—Melphalan—ovarian cancer	0.000223	0.00291	CcSEcCtD
Rilpivirine—Immune system disorder—Docetaxel—ovarian cancer	0.000222	0.0029	CcSEcCtD
Rilpivirine—Rash—Melphalan—ovarian cancer	0.000221	0.00289	CcSEcCtD
Rilpivirine—Dermatitis—Melphalan—ovarian cancer	0.000221	0.00288	CcSEcCtD
Rilpivirine—Asthenia—Vinorelbine—ovarian cancer	0.00022	0.00287	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000216	0.00282	CcSEcCtD
Rilpivirine—Mental disorder—Docetaxel—ovarian cancer	0.000215	0.00281	CcSEcCtD
Rilpivirine—Anxiety—Paclitaxel—ovarian cancer	0.000214	0.0028	CcSEcCtD
Rilpivirine—Malnutrition—Docetaxel—ovarian cancer	0.000214	0.00279	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000213	0.00279	CcSEcCtD
Rilpivirine—Nausea—Topotecan—ovarian cancer	0.000212	0.00278	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000211	0.00276	CcSEcCtD
Rilpivirine—Dry mouth—Paclitaxel—ovarian cancer	0.00021	0.00274	CcSEcCtD
Rilpivirine—Diarrhoea—Vinorelbine—ovarian cancer	0.000209	0.00274	CcSEcCtD
Rilpivirine—Nausea—Melphalan—ovarian cancer	0.000208	0.00272	CcSEcCtD
Rilpivirine—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000208	0.00271	CcSEcCtD
Rilpivirine—Infection—Paclitaxel—ovarian cancer	0.000204	0.00267	CcSEcCtD
Rilpivirine—Dizziness—Vinorelbine—ovarian cancer	0.000202	0.00264	CcSEcCtD
Rilpivirine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000202	0.00264	CcSEcCtD
Rilpivirine—Skin disorder—Paclitaxel—ovarian cancer	0.0002	0.00261	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000199	0.00261	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000195	0.00255	CcSEcCtD
Rilpivirine—Vomiting—Vinorelbine—ovarian cancer	0.000195	0.00254	CcSEcCtD
Rilpivirine—Rash—Vinorelbine—ovarian cancer	0.000193	0.00252	CcSEcCtD
Rilpivirine—Dermatitis—Vinorelbine—ovarian cancer	0.000193	0.00252	CcSEcCtD
Rilpivirine—Headache—Vinorelbine—ovarian cancer	0.000192	0.0025	CcSEcCtD
Rilpivirine—Insomnia—Paclitaxel—ovarian cancer	0.000186	0.00243	CcSEcCtD
Rilpivirine—Somnolence—Paclitaxel—ovarian cancer	0.000183	0.00239	CcSEcCtD
Rilpivirine—Nausea—Vinorelbine—ovarian cancer	0.000182	0.00238	CcSEcCtD
Rilpivirine—Renal failure—Epirubicin—ovarian cancer	0.000181	0.00237	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000181	0.00236	CcSEcCtD
Rilpivirine—Decreased appetite—Paclitaxel—ovarian cancer	0.000179	0.00234	CcSEcCtD
Rilpivirine—Dry mouth—Docetaxel—ovarian cancer	0.000178	0.00233	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000178	0.00232	CcSEcCtD
Rilpivirine—Fatigue—Paclitaxel—ovarian cancer	0.000177	0.00232	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000174	0.00228	CcSEcCtD
Rilpivirine—Infection—Docetaxel—ovarian cancer	0.000173	0.00226	CcSEcCtD
Rilpivirine—Nervous system disorder—Docetaxel—ovarian cancer	0.000171	0.00224	CcSEcCtD
Rilpivirine—Skin disorder—Docetaxel—ovarian cancer	0.000169	0.00221	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000168	0.0022	CcSEcCtD
Rilpivirine—Renal failure—Doxorubicin—ovarian cancer	0.000168	0.00219	CcSEcCtD
Rilpivirine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000164	0.00214	CcSEcCtD
Rilpivirine—Abdominal pain—Paclitaxel—ovarian cancer	0.000163	0.00213	CcSEcCtD
Rilpivirine—Urethral disorder—Epirubicin—ovarian cancer	0.000162	0.00212	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000161	0.00211	CcSEcCtD
Rilpivirine—Insomnia—Docetaxel—ovarian cancer	0.000158	0.00206	CcSEcCtD
Rilpivirine—Somnolence—Docetaxel—ovarian cancer	0.000155	0.00203	CcSEcCtD
Rilpivirine—Decreased appetite—Docetaxel—ovarian cancer	0.000152	0.00198	CcSEcCtD
Rilpivirine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000151	0.00198	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000151	0.00197	CcSEcCtD
Rilpivirine—Fatigue—Docetaxel—ovarian cancer	0.00015	0.00197	CcSEcCtD
Rilpivirine—Urethral disorder—Doxorubicin—ovarian cancer	0.00015	0.00196	CcSEcCtD
Rilpivirine—Immune system disorder—Epirubicin—ovarian cancer	0.00015	0.00195	CcSEcCtD
Rilpivirine—Asthenia—Paclitaxel—ovarian cancer	0.000148	0.00193	CcSEcCtD
Rilpivirine—Mental disorder—Epirubicin—ovarian cancer	0.000145	0.0019	CcSEcCtD
Rilpivirine—Malnutrition—Epirubicin—ovarian cancer	0.000144	0.00188	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000143	0.00186	CcSEcCtD
Rilpivirine—Diarrhoea—Paclitaxel—ovarian cancer	0.000141	0.00184	CcSEcCtD
Rilpivirine—Immune system disorder—Doxorubicin—ovarian cancer	0.000138	0.00181	CcSEcCtD
Rilpivirine—Abdominal pain—Docetaxel—ovarian cancer	0.000138	0.0018	CcSEcCtD
Rilpivirine—Dizziness—Paclitaxel—ovarian cancer	0.000136	0.00178	CcSEcCtD
Rilpivirine—Mental disorder—Doxorubicin—ovarian cancer	0.000134	0.00175	CcSEcCtD
Rilpivirine—Malnutrition—Doxorubicin—ovarian cancer	0.000133	0.00174	CcSEcCtD
Rilpivirine—Vomiting—Paclitaxel—ovarian cancer	0.000131	0.00171	CcSEcCtD
Rilpivirine—Rash—Paclitaxel—ovarian cancer	0.00013	0.0017	CcSEcCtD
Rilpivirine—Dermatitis—Paclitaxel—ovarian cancer	0.00013	0.00169	CcSEcCtD
Rilpivirine—Headache—Paclitaxel—ovarian cancer	0.000129	0.00168	CcSEcCtD
Rilpivirine—Asthenia—Docetaxel—ovarian cancer	0.000125	0.00164	CcSEcCtD
Rilpivirine—Anxiety—Epirubicin—ovarian cancer	0.000122	0.0016	CcSEcCtD
Rilpivirine—Nausea—Paclitaxel—ovarian cancer	0.000122	0.0016	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000122	0.00159	CcSEcCtD
Rilpivirine—Dry mouth—Epirubicin—ovarian cancer	0.00012	0.00157	CcSEcCtD
Rilpivirine—Diarrhoea—Docetaxel—ovarian cancer	0.000119	0.00156	CcSEcCtD
Rilpivirine—Infection—Epirubicin—ovarian cancer	0.000117	0.00153	CcSEcCtD
Rilpivirine—Nervous system disorder—Epirubicin—ovarian cancer	0.000115	0.00151	CcSEcCtD
Rilpivirine—Dizziness—Docetaxel—ovarian cancer	0.000115	0.00151	CcSEcCtD
Rilpivirine—Skin disorder—Epirubicin—ovarian cancer	0.000114	0.00149	CcSEcCtD
Rilpivirine—Anxiety—Doxorubicin—ovarian cancer	0.000113	0.00148	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000113	0.00147	CcSEcCtD
Rilpivirine—Dry mouth—Doxorubicin—ovarian cancer	0.000111	0.00145	CcSEcCtD
Rilpivirine—Vomiting—Docetaxel—ovarian cancer	0.000111	0.00145	CcSEcCtD
Rilpivirine—Rash—Docetaxel—ovarian cancer	0.00011	0.00144	CcSEcCtD
Rilpivirine—Dermatitis—Docetaxel—ovarian cancer	0.00011	0.00144	CcSEcCtD
Rilpivirine—Headache—Docetaxel—ovarian cancer	0.000109	0.00143	CcSEcCtD
Rilpivirine—Infection—Doxorubicin—ovarian cancer	0.000108	0.00141	CcSEcCtD
Rilpivirine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000107	0.0014	CcSEcCtD
Rilpivirine—Insomnia—Epirubicin—ovarian cancer	0.000106	0.00139	CcSEcCtD
Rilpivirine—Skin disorder—Doxorubicin—ovarian cancer	0.000106	0.00138	CcSEcCtD
Rilpivirine—Somnolence—Epirubicin—ovarian cancer	0.000105	0.00137	CcSEcCtD
Rilpivirine—Nausea—Docetaxel—ovarian cancer	0.000104	0.00135	CcSEcCtD
Rilpivirine—Decreased appetite—Epirubicin—ovarian cancer	0.000102	0.00134	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000102	0.00133	CcSEcCtD
Rilpivirine—Fatigue—Epirubicin—ovarian cancer	0.000101	0.00133	CcSEcCtD
Rilpivirine—Insomnia—Doxorubicin—ovarian cancer	9.85e-05	0.00129	CcSEcCtD
Rilpivirine—Somnolence—Doxorubicin—ovarian cancer	9.68e-05	0.00126	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Epirubicin—ovarian cancer	9.62e-05	0.00126	CcSEcCtD
Rilpivirine—Decreased appetite—Doxorubicin—ovarian cancer	9.46e-05	0.00124	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	9.4e-05	0.00123	CcSEcCtD
Rilpivirine—Fatigue—Doxorubicin—ovarian cancer	9.39e-05	0.00123	CcSEcCtD
Rilpivirine—Abdominal pain—Epirubicin—ovarian cancer	9.3e-05	0.00122	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Doxorubicin—ovarian cancer	8.9e-05	0.00116	CcSEcCtD
Rilpivirine—Abdominal pain—Doxorubicin—ovarian cancer	8.61e-05	0.00112	CcSEcCtD
Rilpivirine—Asthenia—Epirubicin—ovarian cancer	8.44e-05	0.0011	CcSEcCtD
Rilpivirine—Diarrhoea—Epirubicin—ovarian cancer	8.05e-05	0.00105	CcSEcCtD
Rilpivirine—Asthenia—Doxorubicin—ovarian cancer	7.81e-05	0.00102	CcSEcCtD
Rilpivirine—Dizziness—Epirubicin—ovarian cancer	7.78e-05	0.00102	CcSEcCtD
Rilpivirine—Vomiting—Epirubicin—ovarian cancer	7.48e-05	0.000978	CcSEcCtD
Rilpivirine—Diarrhoea—Doxorubicin—ovarian cancer	7.45e-05	0.000973	CcSEcCtD
Rilpivirine—Rash—Epirubicin—ovarian cancer	7.42e-05	0.000969	CcSEcCtD
Rilpivirine—Dermatitis—Epirubicin—ovarian cancer	7.41e-05	0.000969	CcSEcCtD
Rilpivirine—Headache—Epirubicin—ovarian cancer	7.37e-05	0.000963	CcSEcCtD
Rilpivirine—Dizziness—Doxorubicin—ovarian cancer	7.2e-05	0.000941	CcSEcCtD
Rilpivirine—Nausea—Epirubicin—ovarian cancer	6.99e-05	0.000913	CcSEcCtD
Rilpivirine—Vomiting—Doxorubicin—ovarian cancer	6.92e-05	0.000905	CcSEcCtD
Rilpivirine—Rash—Doxorubicin—ovarian cancer	6.86e-05	0.000897	CcSEcCtD
Rilpivirine—Dermatitis—Doxorubicin—ovarian cancer	6.86e-05	0.000896	CcSEcCtD
Rilpivirine—Headache—Doxorubicin—ovarian cancer	6.82e-05	0.000891	CcSEcCtD
Rilpivirine—Nausea—Doxorubicin—ovarian cancer	6.47e-05	0.000845	CcSEcCtD
Rilpivirine—ABCG2—Metabolism—NME2—ovarian cancer	3.87e-05	0.00165	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.75e-05	0.0016	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—PPP2R1A—ovarian cancer	3.57e-05	0.00152	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.55e-05	0.00151	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	3.52e-05	0.0015	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PPP1CC—ovarian cancer	3.51e-05	0.00149	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—BRIP1—ovarian cancer	3.51e-05	0.00149	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	3.47e-05	0.00148	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	3.47e-05	0.00148	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	3.36e-05	0.00143	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	3.36e-05	0.00143	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	3.29e-05	0.0014	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	3.17e-05	0.00135	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	3.1e-05	0.00132	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.07e-05	0.00131	CbGpPWpGaD
Rilpivirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	3.06e-05	0.0013	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	2.97e-05	0.00126	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.89e-05	0.00123	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NME2—ovarian cancer	2.84e-05	0.00121	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	2.8e-05	0.00119	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	2.79e-05	0.00119	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	2.76e-05	0.00118	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	2.74e-05	0.00117	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—MYC—ovarian cancer	2.73e-05	0.00116	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.71e-05	0.00116	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.7e-05	0.00115	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	2.7e-05	0.00115	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CYTB—ovarian cancer	2.69e-05	0.00115	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	2.68e-05	0.00114	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	2.68e-05	0.00114	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CASP3—ovarian cancer	2.68e-05	0.00114	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL2—ovarian cancer	2.67e-05	0.00114	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.63e-05	0.00112	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	2.62e-05	0.00112	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.61e-05	0.00111	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	2.6e-05	0.00111	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	2.57e-05	0.00109	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	2.57e-05	0.00109	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.55e-05	0.00109	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	2.55e-05	0.00109	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—ESR1—ovarian cancer	2.53e-05	0.00108	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	2.52e-05	0.00107	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	2.52e-05	0.00107	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	2.52e-05	0.00107	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.5e-05	0.00107	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CYTB—ovarian cancer	2.5e-05	0.00106	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.42e-05	0.00103	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	2.38e-05	0.00101	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PPP1CC—ovarian cancer	2.36e-05	0.001	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—BRIP1—ovarian cancer	2.36e-05	0.001	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—YAP1—ovarian cancer	2.35e-05	0.001	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.33e-05	0.000991	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	2.27e-05	0.000967	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—BRIP1—ovarian cancer	2.18e-05	0.000929	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PPP1CC—ovarian cancer	2.18e-05	0.000929	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NME2—ovarian cancer	2.14e-05	0.000913	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	2.12e-05	0.000901	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.11e-05	0.0009	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NME2—ovarian cancer	2.09e-05	0.000891	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.09e-05	0.000888	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.06e-05	0.000878	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.05e-05	0.000871	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.03e-05	0.000864	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	2.02e-05	0.00086	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	1.98e-05	0.000844	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—FASN—ovarian cancer	1.92e-05	0.000816	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.91e-05	0.000813	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—SLC5A5—ovarian cancer	1.89e-05	0.000803	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	1.87e-05	0.000798	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYTB—ovarian cancer	1.83e-05	0.000779	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—SLC2A1—ovarian cancer	1.82e-05	0.000775	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.82e-05	0.000775	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.78e-05	0.000759	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CYP1B1—ovarian cancer	1.75e-05	0.000743	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.72e-05	0.000731	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	1.67e-05	0.000713	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NME2—ovarian cancer	1.67e-05	0.000712	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—BRIP1—ovarian cancer	1.6e-05	0.000681	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PPP1CC—ovarian cancer	1.6e-05	0.000681	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—YAP1—ovarian cancer	1.58e-05	0.000673	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.56e-05	0.000666	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PPP2R1A—ovarian cancer	1.55e-05	0.000659	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.54e-05	0.000656	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.48e-05	0.000632	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—YAP1—ovarian cancer	1.46e-05	0.000623	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.46e-05	0.00062	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ABCB1—ovarian cancer	1.44e-05	0.000612	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.42e-05	0.000604	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—TYMS—ovarian cancer	1.41e-05	0.000601	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYTB—ovarian cancer	1.38e-05	0.000589	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.37e-05	0.000585	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.35e-05	0.000577	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.35e-05	0.000575	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—MAPK3—ovarian cancer	1.35e-05	0.000575	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYTB—ovarian cancer	1.35e-05	0.000574	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.35e-05	0.000574	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.32e-05	0.000562	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—MYC—ovarian cancer	1.31e-05	0.000559	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.31e-05	0.000557	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NME2—ovarian cancer	1.29e-05	0.000549	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—FASN—ovarian cancer	1.29e-05	0.000548	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.29e-05	0.000548	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.27e-05	0.000542	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	1.27e-05	0.000539	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.24e-05	0.000528	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	1.22e-05	0.000521	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.21e-05	0.000514	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.21e-05	0.000514	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.2e-05	0.00051	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—FASN—ovarian cancer	1.19e-05	0.000508	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.18e-05	0.000502	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—BRIP1—ovarian cancer	1.18e-05	0.000502	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	1.17e-05	0.000499	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.17e-05	0.000499	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.16e-05	0.000492	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CAV1—ovarian cancer	1.14e-05	0.000484	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.13e-05	0.000482	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.12e-05	0.000477	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.09e-05	0.000463	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.09e-05	0.000462	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYTB—ovarian cancer	1.08e-05	0.000459	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—YAP1—ovarian cancer	1.07e-05	0.000457	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.06e-05	0.000452	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.05e-05	0.000448	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	1.04e-05	0.000443	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CG—ovarian cancer	1.04e-05	0.000441	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.04e-05	0.000441	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.03e-05	0.000439	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.01e-05	0.00043	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.01e-05	0.00043	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ABCB1—ovarian cancer	9.66e-06	0.000411	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PPP2R1A—ovarian cancer	9.63e-06	0.00041	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	9.53e-06	0.000406	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—TYMS—ovarian cancer	9.49e-06	0.000404	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPP1CC—ovarian cancer	9.41e-06	0.000401	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—BRIP1—ovarian cancer	9.41e-06	0.000401	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—AKT1—ovarian cancer	9.11e-06	0.000388	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CD—ovarian cancer	9.11e-06	0.000388	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ABCB1—ovarian cancer	8.94e-06	0.000381	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.8e-06	0.000375	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—TYMS—ovarian cancer	8.78e-06	0.000374	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	8.76e-06	0.000373	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—FASN—ovarian cancer	8.74e-06	0.000372	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—SLC5A5—ovarian cancer	8.6e-06	0.000366	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.47e-06	0.000361	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYTB—ovarian cancer	8.31e-06	0.000354	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—SLC2A1—ovarian cancer	8.3e-06	0.000354	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—YAP1—ovarian cancer	8.1e-06	0.000345	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.02e-06	0.000341	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYP1B1—ovarian cancer	7.96e-06	0.000339	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CB—ovarian cancer	7.94e-06	0.000338	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—YAP1—ovarian cancer	7.91e-06	0.000337	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CAV1—ovarian cancer	7.64e-06	0.000325	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.3e-06	0.000311	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.26e-06	0.000309	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.26e-06	0.000309	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.15e-06	0.000305	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CAV1—ovarian cancer	7.08e-06	0.000301	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	7.06e-06	0.000301	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.05e-06	0.0003	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	6.96e-06	0.000296	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTEN—ovarian cancer	6.86e-06	0.000292	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.86e-06	0.000292	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—FASN—ovarian cancer	6.61e-06	0.000281	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ABCB1—ovarian cancer	6.56e-06	0.000279	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SLC5A5—ovarian cancer	6.5e-06	0.000277	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CG—ovarian cancer	6.45e-06	0.000275	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—FASN—ovarian cancer	6.45e-06	0.000275	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—TYMS—ovarian cancer	6.44e-06	0.000274	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.34e-06	0.00027	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—YAP1—ovarian cancer	6.31e-06	0.000269	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SLC2A1—ovarian cancer	6.28e-06	0.000267	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.25e-06	0.000266	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.14e-06	0.000262	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.12e-06	0.000261	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	6.12e-06	0.000261	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP1B1—ovarian cancer	6.02e-06	0.000256	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP1B1—ovarian cancer	5.87e-06	0.00025	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CD—ovarian cancer	5.67e-06	0.000241	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.49e-06	0.000234	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	5.34e-06	0.000227	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	5.34e-06	0.000227	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.31e-06	0.000226	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.21e-06	0.000222	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CAV1—ovarian cancer	5.19e-06	0.000221	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—FASN—ovarian cancer	5.15e-06	0.000219	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SLC5A5—ovarian cancer	5.06e-06	0.000216	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ABCB1—ovarian cancer	4.95e-06	0.000211	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CB—ovarian cancer	4.94e-06	0.00021	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SLC2A1—ovarian cancer	4.89e-06	0.000208	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—YAP1—ovarian cancer	4.87e-06	0.000207	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—TYMS—ovarian cancer	4.87e-06	0.000207	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	4.84e-06	0.000206	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.79e-06	0.000204	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—TYMS—ovarian cancer	4.75e-06	0.000202	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CG—ovarian cancer	4.73e-06	0.000201	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP1B1—ovarian cancer	4.69e-06	0.0002	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTEN—ovarian cancer	4.61e-06	0.000196	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTEN—ovarian cancer	4.27e-06	0.000182	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	4.16e-06	0.000177	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CD—ovarian cancer	4.15e-06	0.000177	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.14e-06	0.000176	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—FASN—ovarian cancer	3.97e-06	0.000169	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—AKT1—ovarian cancer	3.95e-06	0.000168	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CAV1—ovarian cancer	3.92e-06	0.000167	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.91e-06	0.000166	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.86e-06	0.000164	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CAV1—ovarian cancer	3.83e-06	0.000163	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—TYMS—ovarian cancer	3.79e-06	0.000161	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.77e-06	0.000161	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.75e-06	0.000159	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CB—ovarian cancer	3.62e-06	0.000154	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.62e-06	0.000154	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CG—ovarian cancer	3.57e-06	0.000152	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.49e-06	0.000148	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	3.25e-06	0.000138	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.21e-06	0.000137	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	3.14e-06	0.000134	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTEN—ovarian cancer	3.13e-06	0.000133	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.06e-06	0.00013	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CAV1—ovarian cancer	3.05e-06	0.00013	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PIK3CA—ovarian cancer	3.01e-06	0.000128	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.98e-06	0.000127	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—TYMS—ovarian cancer	2.93e-06	0.000125	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.92e-06	0.000124	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.78e-06	0.000118	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.74e-06	0.000117	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.67e-06	0.000114	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—AKT1—ovarian cancer	2.66e-06	0.000113	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—AKT1—ovarian cancer	2.46e-06	0.000105	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.45e-06	0.000104	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTEN—ovarian cancer	2.36e-06	0.000101	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CAV1—ovarian cancer	2.36e-06	0.0001	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTEN—ovarian cancer	2.31e-06	9.83e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	2.21e-06	9.4e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.15e-06	9.14e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.13e-06	9.08e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.89e-06	8.04e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTEN—ovarian cancer	1.84e-06	7.85e-05	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—AKT1—ovarian cancer	1.8e-06	7.68e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.67e-06	7.1e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.65e-06	7.01e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.63e-06	6.93e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.42e-06	6.05e-05	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—AKT1—ovarian cancer	1.36e-06	5.8e-05	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—AKT1—ovarian cancer	1.33e-06	5.66e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.3e-06	5.53e-05	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—AKT1—ovarian cancer	1.06e-06	4.52e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1e-06	4.27e-05	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—AKT1—ovarian cancer	8.19e-07	3.49e-05	CbGpPWpGaD
